Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Ontology highlight
ABSTRACT: This is a study to assess the combination of PXD101 and 5-Fluorouracil (5-FU)in patients with advanced solid tumors. The primary goal of the study is to understand the safety, anti-tumor activity, and how the study drug behaves within the body when given with 5-Fluorouracil (5-FU).
DISEASE(S): Lung Cancer,Sarcoma,Colorectal Cancer,Mesothelioma,Bladder Cancer,Breast Cancer,Lung Neoplasms,Neoplasms,Ovarian Cancer,Esophageal Neoplasms,Thyroid Cancer,Advanced Solid Tumor,Tumor,Carcinoma, Non-small-cell Lung,Head And Neck Cancer
PROVIDER: 2035464 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA